Thrombolytic Science International
Cambridge · Founded 2004
About Thrombolytic Science International
Thrombolytic Science is focused on developing a proprietary product, M5, a mutant of pro-urokinase (proUK). M5 is a thrombolytic that follows a different paradigm than tPA, has superior efficacy and is accompanied by little bleeding risk.
Company Facts
- Founded: 2004
- Legal name: Thrombolytic Science, LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.5M
- Last round: Series Unknown (Jan 2012)
- Website: tsillc.net
- Phone: +1 617-661-1103
Social Profiles
Canonical: https://fsome.com/organization/thrombolytic-science-international-8243440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.